What is the standard dosing of Vyvanse (lisdexamfetamine) for attention deficit hyperactivity disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Standard Dosing of Vyvanse (Lisdexamfetamine) for ADHD

Start Vyvanse at 30 mg once daily in the morning, then increase by 10-20 mg increments at weekly intervals to a maximum of 70 mg daily. 1

Starting Dose

  • Begin with 30 mg once daily taken in the early morning (with or without food) for both adults and children aged 6 years and older 1
  • Morning administration is essential to prevent insomnia 1
  • Alternative starting approaches include 20-30 mg in some guideline recommendations, though the FDA label specifies 30 mg as the standard starting dose 2, 1

Titration Protocol

  • Increase the dose in increments of 10 mg or 20 mg at approximately weekly intervals based on symptom control and tolerability 1
  • Continue titration until optimal symptom control is achieved without intolerable side effects 3
  • Use standardized ADHD rating scales (such as ADHD-RS-IV) from patients, parents, or teachers before each dose increase to objectively guide titration decisions 3

Maximum Dose

  • The maximum recommended dose is 70 mg once daily for both adults and children 1
  • This represents the ceiling dose regardless of age or severity of symptoms 1

Administration Options

Vyvanse can be taken in two ways 1:

  • Swallow the capsule whole, or
  • Open the capsule and mix the entire contents with yogurt, water, or orange juice—consume the mixture immediately and do not store it 1
  • Do not divide a single dose; always take at least one full capsule per day 1

Special Population Dosing Adjustments

Renal impairment requires dose reduction 1:

  • Severe renal impairment (GFR 15 to <30 mL/min/1.73 m²): Maximum dose 50 mg daily 1
  • End-stage renal disease (GFR <15 mL/min/1.73 m²): Maximum dose 30 mg daily 1

Critical Monitoring Requirements

Before starting treatment 3, 1:

  • Assess for cardiac disease through careful history, family history of sudden death or ventricular arrhythmia, and physical examination 1
  • Evaluate for motor or verbal tics or Tourette's syndrome 1
  • Obtain baseline blood pressure, pulse, height, and weight 3

During titration and ongoing treatment 3:

  • Monitor blood pressure, pulse, height, and weight at each visit 3
  • Collect symptom ratings using standardized scales before each dose increase 3
  • Systematically assess for side effects at each adjustment 3

Duration of Effect

  • Vyvanse provides efficacy throughout a full treatment day, with demonstrated effectiveness from 1.5 hours through 13 hours post-dose in pediatric studies 4
  • In adults, efficacy has been demonstrated up to 14 hours post-dose 5
  • This extended duration makes it suitable for managing ADHD symptoms that extend late into the day 5

Common Pitfalls to Avoid

  • Do not start at doses higher than 30 mg, as this leads to unnecessary side effects and decreased adherence 1
  • Do not take afternoon doses, as this significantly increases the risk of insomnia 1
  • Do not continue escalating the dose if symptom control plateaus at lower doses—consider switching medications or adding non-stimulant options instead 3
  • Do not use agents that alter urinary pH without dose adjustment, as acidifying agents (e.g., ascorbic acid) decrease blood levels while alkalinizing agents (e.g., sodium bicarbonate) increase blood levels 1

Unique Pharmacologic Considerations

  • Lisdexamfetamine is a prodrug that remains inactive until enzymatic conversion (predominantly by red blood cells) to d-amphetamine and lysine 5
  • This prodrug formulation provides lower abuse potential compared to other amphetamines, which is particularly relevant for adolescents and adults with substance use concerns 3, 6
  • The medication follows linear pharmacokinetics at therapeutic doses (30-70 mg) 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.